A review of IVF in PCOS patients at risk of ovarian hyperstimulation syndrome

被引:31
|
作者
Thakre, Nisha [1 ]
Homburg, Roy [1 ]
机构
[1] Homerton Univ Hosp Fdn Trust, Homerton Fertil Ctr, London, England
关键词
PCOS; IVF; GnRH agonist trigger; segmentation of IVF; IN-VITRO FERTILIZATION; GNRH-AGONIST; OOCYTE MATURATION; POLYCYSTIC OVARIES; SYNDROME OHSS; PREVENTION; WOMEN; STIMULATION; HORMONE; TRIGGER;
D O I
10.1080/17446651.2019.1631797
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Polycystic ovarian syndrome (PCOS) is the commonest endocrinopathy affecting women in the reproductive age group. The prevalence may vary from 8.7% to 17% depending on the clinical criteria used. PCOS women having IVF presents multiple challenges ranging from a poor to an exaggerated response, poor egg to follicle ratio, poor fertilisation, poor blastocyst conversion and ovarian hyperstimulation syndrome. Ovarian stimulation should be planned with attention paid to the AMH, antral follicle count and LH in particular. The dose of the stimulating gonadotrophin should be planned to achieve an optimal response during a GnRH antagonist cycle. Areas covered: We obtained evidence from chapters, case studies, practice committee reports, randomised controlled trials, Cochrane and systematic reviews. Expert opinion: IVF for PCOS is challenging. We have reached an understanding of careful low dose stimulation of ovaries considering AMH and antral follicle count. PCOS women should have the GnRH agonist trigger and freezing of embryos. Segmentation of an IVF cycle in PCOS woman makes it safer and has better outcome
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [1] A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients
    Delvigne, A
    Rozenberg, S
    HUMAN REPRODUCTION UPDATE, 2002, 8 (03) : 291 - 296
  • [2] Effect of heparin administration in moderate-severe ovarian hyperstimulation syndrome in PCOS patients undergoing controlled ovarian hyperstimulation
    Vanlioglu, F.
    Karlikaya, G.
    Karagozoglu, H.
    Lacin, S.
    Guney, A.
    Ozturk, E.
    Kahraman, S.
    HUMAN REPRODUCTION, 2007, 22 : I147 - I148
  • [3] RISK OF OVARIAN TORSION IN PATIENTS WITH OVARIAN HYPERSTIMULATION SYNDROME.
    Mandelbaum, R.
    Matsuo, K.
    Awadalla, M.
    Shoupe, D.
    Chung, K.
    FERTILITY AND STERILITY, 2019, 111 (04) : E50 - E51
  • [4] HIGH EFFICACY OF EMBRYO VITRIFICATION IN IVF PATIENTS AT RISK OF SEVERE/MODERATE OVARIAN HYPERSTIMULATION SYNDROME (OHSS).
    Mifsud, A.
    Escriba, M-J.
    De los Santos, M-J.
    Remohi, J.
    Galan, A.
    Cobo, A.
    FERTILITY AND STERILITY, 2013, 100 (03) : S177 - S178
  • [5] Nursing protocol for the risk identification and prevention of Ovarian Hyperstimulation Syndrome (OHSS) in patients undergoing IVF treatment
    Figueiredo, T.
    Silva, L.
    Bonetti, T.
    Motta, E.
    Serafini, P.
    Panzan, M.
    Torelli, F.
    Assi, J.
    HUMAN REPRODUCTION, 2017, 32 : 382 - 383
  • [6] Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome
    Raziel, A
    Friedler, S
    Schachter, M
    Strassburger, D
    Mordechai, E
    Ron-El, R
    HUMAN REPRODUCTION, 2002, 17 (01) : 107 - 110
  • [7] Ovarian Hyperstimulation Syndrome, Pregnancy, Live Birth and IVF Cycle Failure by Risk Category
    Devroey, P.
    Humaidan, P.
    Gordon, K.
    Gates, D.
    Stegmann, B.
    HUMAN REPRODUCTION, 2015, 30 : 81 - 81
  • [8] Polycystic ovarian syndrome (PCOS) patients have a favorable response to ganirelix acetate during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF)-embryo transfer (ET).
    Bracero, N
    Jurema, M
    Vlahos, N
    Kolp, L
    Garcia, J
    FERTILITY AND STERILITY, 2002, 78 (03) : S149 - S150
  • [9] Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome (OHSS)
    Raziel, A
    Friedler, S
    Schachter, M
    Strassburger, D
    Komarovsky, D
    Bern, O
    Kasterstein, E
    Ron-El, R
    HUMAN REPRODUCTION, 2000, 15 : 96 - 96
  • [10] The role of Loratadin in prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSI cycles
    Madani, T.
    Ashrafi, M.
    Khafri, S.
    Irani, S.
    HUMAN REPRODUCTION, 2007, 22 : I146 - I146